https://www.selleckchem.com/pr....oducts/zanubrutini-b
The current phase III EORTC 1420 Best-of trial (NCT0298441 compares the swallowing function after transoral surgery versus intensity modulated radiotherapy (RT) in patients with early-stage carcinoma of the oropharynx, supraglottis and hypopharynx. We report the analysis of the Benchmark Case (BC) procedures before patient recruitment with special attention to dysphagia/aspiration related structures (DARS). Submitted RT volumes and plans from participating centers were analyzed and compared against the gold-standard exper
Like
Comment
Share
